Anti tumor drug safety evaluation platform
Service items
It can carry out safety evaluation of anti-tumor drugs with different targets, especially in long-term clinical intravenous drug use. It has a mature technical system. At present, it has established an evaluation system for rats and dogs with continuous intravenous drip for three months.
■ Pharmacodynamic study
■ Single dose toxicity test (rodents and non rodents)
■ Repeated dose toxicity test (rodents and non rodents)
■ Safety pharmacology test
■ Toxic/pharmacokinetic test
■ Reproductive toxicity test (I, II, III)
■ Genotoxicity test
■ Local toxicity test
■ Immunogenicity test
■ Pharmacodynamic study
■ Single dose toxicity test (rodents and non rodents)
■ Repeated dose toxicity test (rodents and non rodents)
■ Safety pharmacology test
■ Toxic/pharmacokinetic test
■ Reproductive toxicity test (I, II, III)
■ Genotoxicity test
■ Local toxicity test
■ Immunogenicity test
Cooperative enterprises(Only some cooperative enterprises are displayed)
Company performance - obtaining clinical approval(Only some Company performance are displayed)
| Drug name | Acceptance No | Indication | Class |
| STC008 injection solution | CXHL2400395 | It is used to treat tumor liquid liquids of non -small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer. | 1 |
| HL-21 | coronavirus | 1 | |
| K-5A2 tablets | CXHL2300019 | This product is combined with other anti-reverse virus drugs. It is suitable for treatment of type I immune defect virus (HIV-1) infected with adult patients with the experience experience experience | 1 |
| HL-003 tablets | CXHL2200717 | This product is intended to be used for the protection of chemotherapy | 1 |
| Ethylene glycol Ilidekang for injection | CXHL2200081 | It is intended to treat brain tumor | 1 |
| YK-029A | CXHL2200062 | Non -small cell lung carcinoma | 1 |
| YK-029A film | CXHL2101515 | Late NSCC | Chemical Drug Class 1 |
| AST-1601 | CXHL2101360 | Clinically intended to treat chronic myeline leukemia, especially chronic myeline leukemia that failed or resistant to the treatment of tyrosine kinase inhibitors | Chemical Drug Class 1 |
| LBG-1600M film | CXHL2000624 | Appropriate dermatitis | 1 |
| Foma Nipoofovir Movie | CXHL1800141 | For the treatment of chronic hepatitis B virus (HBV) infection. | 1 |
